Kallikrein-4 (KLK4) is a serine protease expressed during enamel maturation, and proteolytic processing of the enamel matrix by KLK4 is critical for proper enamel formation. KLK4 is secreted as an inactive zymogen (pro-KLK4), and identification of its activator remains elusive. Dipeptidyl peptidase I (DPPI) is a cysteine aminopeptidase that can activate several serine proteases. In this study, we sought to examine DPPI expression in mouse enamel organ and determine if DPPI could activate KLK4. Real-time PCR showed DPPI expression throughout amelogenesis, with highest expression at maturation, and immunohistochemical staining of mouse incisors confirmed DPPI expression by ameloblasts. We demonstrate in vitro that DPPI activates pro-KLK4 to cleave a fluorogenic peptide containing a KLK4 cleavage site. Examination of mature enamel from DPPI null mice by FTIR showed no significant accumulation of protein; however, microhardness testing revealed that loss of DPPI expression significantly reduced enamel hardness.
Get full access to this article
View all access options for this article.
References
1.
Adkison AM, Raptis SZ, Kelley DG, Pham CT -2002-. Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis. J Clin Invest109:363–371.
2.
Dong Y, Kaushal A, Bui L, Chu S, Fuller PJ, Nicklin J, et al. -2001-. Human kallikrein 4 -KLK4- is highly expressed in serous ovarian carcinomas. Clin Cancer Res7:2363–2371.
3.
Emami N, Diamandis EP -2008-. Human kallikrein-related peptidase 14 -KLK14- is a new activator component of the KLK proteolytic cascade. Possible function in seminal plasma and skin. J Biol Chem283:3031–3041.
4.
Hart PS, Hart TC, Michalec MD, Ryu OH, Simmons D, Hong S, et al. -2004-. Mutation in kallikrein 4 causes autosomal recessive hypomaturation amelogenesis imperfecta. J Med Genet41:545–549.
5.
Hart TC, Shapira L -1994-. Papillon-Lefèvre syndrome. Periodontol 20006:88–100.
6.
Hart TC, Hart PS, Bowden DW, Michalec MD, Callison SA, Walker SJ, et al. -1999-. Mutations of the cathepsin C gene are responsible for Papillon-Lefèvre syndrome. J Med Genet36:881–887.
7.
Hu JC, Ryu OH, Chen JJ, Uchida T, Wakida K, Murakami C, et al. -2000-. Localization of EMSP1 expression during tooth formation and cloning of mouse cDNA. J Dent Res79:70–76.
8.
Hu JC, Sun X, Zhang C, Liu S, Bartlett JD, Simmer JP -2002-. Enamelysin and kallikrein-4 mRNA expression in developing mouse molars. Eur J Oral Sci110:307–315.
9.
Hu Y, Pham CT -2005-. Dipeptidyl peptidase I regulates the development of collagen-induced arthritis. Arthritis Rheum52:2553–2558.
10.
Kerebel B, Clergeau-Guerithault S, Brion M -1975-. [Ultrastructural odontological study of a case of Papillon-Lefevre disease]. Ann Anat Pathol -Paris-20:283–292 [article in French].
11.
Klokk TI, Kilander A, Xi Z, Waehre H, Risberg B, Danielsen HE, et al. -2007-. Kallikrein 4 is a proliferative factor that is overexpressed in prostate cancer. Cancer Res67:5221–5230.
12.
McDonald JK, Zeitman BB, Reilly TJ, Ellis S -1969-. New observations on the substrate specificity of cathepsin C -dipeptidyl aminopeptidase I-. Including the degradation of beta-corticotropin and other peptide hormones. J Biol Chem244:2693–2709.
13.
McGuire MJ, Lipsky PE, Thiele DL -1992-. Purification and characterization of dipeptidyl peptidase I from human spleen. Arch Biochem Biophys295:280–288.
14.
Pagano MB, Bartoli MA, Ennis TL, Mao D, Simmons PM, Thompson RW, et al. -2007-. Critical role of dipeptidyl peptidase I in neutrophil recruitment during the development of experimental abdominal aortic aneurysms. Proc Natl Acad Sci USA104:2855–2860.
15.
Papillon MM, Lefèvre P -1924-. Deux cas de Keratodermie palmaire et plantaire symétrique familiale -Maladie de Meléda- chez le frère et la soeur. Coexistence dans les deux cas d’altérations dentaires graves. Bull Soc Franç Derm Syph31:82–87.
16.
Pfaffl MW -2001-. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res29:e45.
17.
Pham CT, Ley TJ -1999-. Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo. Proc Natl Acad Sci USA96:8627–8632.
18.
Pham CT, Ivanovich JL, Raptis SZ, Zehnbauer B, Ley TJ -2004-. Papillon-Lefèvre syndrome: correlating the molecular, cellular, and clinical consequences of cathepsin C/dipeptidyl peptidase I deficiency in humans. J Immunol173:7277–7281.
19.
Ryu O, Hu JC, Yamakoshi Y, Villemain JL, Cao X, Zhang C, et al. -2002-. Porcine kallikrein-4 activation, glycosylation, activity, and expression in prokaryotic and eukaryotic hosts. Eur J Oral Sci110:358–365.
20.
Toomes C, James J, Wood AJ, Wu CL, McCormick D, Lench N, et al. -1999-. Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis. Nat Genet23:421–424.
21.
Tran TV, Ellis KA, Kam CM, Hudig D, Powers JC -2002-. Dipeptidyl peptidase I: importance of progranzyme activation sequences, other dipeptide sequences, and the N-terminal amino group of synthetic substrates for enzyme activity. Arch Biochem Biophys403:160–170.
22.
Turk BE, Lee DH, Yamakoshi Y, Klingenhoff A, Reichenberger E, Wright JT, et al. -2006-. MMP-20 is predominately a tooth-specific enzyme with a deep catalytic pocket that hydrolyzes type V collagen. Biochemistry45:3863–3874.
23.
Wolters PJ, Raymond WW, Blount JL, Caughey GH -1998-. Regulated expression, processing, and secretion of dog mast cell dipeptidyl peptidase I. J Biol Chem273:15514–15520.
24.
Wolters PJ, Pham CT, Muilenburg DJ, Ley TJ, Caughey GH -2001-. Dipeptidyl peptidase I is essential for activation of mast cell chymases, but not tryptases, in mice. J Biol Chem276:18551–18556.
25.
Wright JT, Daly B, Simmons D, Hong S, Hart SP, Hart TC, et al. -2006-. Human enamel phenotype associated with amelogenesis imperfecta and a kallikrein-4 -g.2142G>A- proteinase mutation. Eur J Oral Sci114-Suppl 1-:13–17.
26.
Yoon H, Laxmikanthan G, Lee J, Blaber SI, Rodriguez A, Kogot JM, et al. -2007-. Activation profiles and regulatory cascades of the human kallikrein-related peptidases. J Biol Chem282:31852–31864.
